Hendrik-Jan Laseur, a business advisor and former banker, has joined the supervisory board of ISA Pharmaceuticals BV of the Netherlands which is developing immunotherapies against cancer and viral infections. Mr Laseur was an executive at ABN Amro Bank for 15 years before founding an advisory firm that supports the work of philanthropic foundations and financial institutions. Mr Laseur studied economics at Erasmus University and the University of Groningen in the Netherlands and holds an MBA from the French business school INSEAD. He succeeds Ronald Loggers, who recently moved from the supervisory board of the company to become the chief executive officer.
ISA Pharmaceuticals announced the appointment on 3 September 2014.
Copyright 2014 Evernow Publishing Ltd